Insulin detemir and Rituximab and hyaluronidase human, recombinant Subcutaneous
Determining the interaction of Insulin detemir and Rituximab and hyaluronidase human, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin Detemir
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab, Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir-Rituximab Intravenous
- Insulin detemir-Riva-Amoxicillin
- Insulin detemir-Rivaroxaban
- Insulin detemir-Rivastigmine
- Insulin detemir-Rivastigmine Capsules
- Insulin detemir-Rivastigmine Oral Solution
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin Detemir (Vials)
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin detemir Subcutaneous
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin glargine
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin Glargine (U-100) Vials